Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00115037 · ClinicalTrials.gov registry record · Phase 4
Managing Alcoholism in People Who Do Not Respond to Naltrexone
A Phase 4 study of Alcoholism, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 302
- Enrollment target
- 1
- Study location
NCT00115037: Completed Phase 4 study of Alcoholism, sponsored by University of Pennsylvania.
NCT00115037 is a Phase 4 study of Alcoholism that has completed, run by University of Pennsylvania. The registered enrollment target is 302 participants, below the 370-participant average among 65 other Alcoholism trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00115037, a Phase 4 study of Alcoholism, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 302 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a study involving treatment for alcohol dependence (alcoholism). The study will combine motivational enhancement therapy and cognitive behavioral therapy (combined behavioral intervention, or CBI) and tests the benefits of continued/discontinued treatment with naltrexone in a randomized placebo-controlled trial. CBI may have advantages in motivating patients to greater medication adherence and may address psychosocial factors that may limit the effects of naltrexone.
Primary Outcome
This is the number of patients who responded to phase 1 treatment based on the definition that subjects were randomly assigned to.
Conditions Studied
Interventions
- DRUG placebo
- DRUG Naltrexone
- BEHAVIORAL Telephone Counseling
- BEHAVIORAL Medication Management (MM)
- BEHAVIORAL Combined Behavioral Intervention (CBI)
Study Locations (1)
Pennsylvania
- University of Pennsylvania Treatment Research Center, Chestnut Street - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 302 participants |
| Start Date | 2003-09 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
What the finished NCT00115037 record still lists
NCT00115037 is an interventional study that assigns participants to a tested intervention. The registered 302 participants enrollment target is mid-sized for trials with a published cap, below the 370-participant average among 65 other Alcoholism trials with a reported enrollment target (18% lower).
The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 5 interventions - of which placebo is the first listed.
NCT00115037 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00115037 about?
NCT00115037 is a clinical study titled "Managing Alcoholism in People Who Do Not Respond to Naltrexone". This is a study involving treatment for alcohol dependence (alcoholism). The study will combine motivational enhancement therapy and cognitive behavioral therapy (combined behavioral intervention, or CBI) and tests the benefits of continued/discontinued treatment with naltrexone in a randomized plac...
What is the current status of trial NCT00115037?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 302 participants. The study started on 2003-09. Estimated completion is 2008-07.
What conditions does trial NCT00115037 study?
This clinical trial studies the following conditions: Alcoholism.
What interventions are being tested in trial NCT00115037?
The interventions under investigation include: placebo (DRUG), Naltrexone (DRUG), Telephone Counseling (BEHAVIORAL), Medication Management (MM) (BEHAVIORAL), Combined Behavioral Intervention (CBI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00115037?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00115037 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00115037's enrollment target sits among peer trials
302 13th of 65 higher than 53 of 65 other Alcoholism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcoholism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Naltrexone in AUD Reward Drinkers
RECRUITING · Phase 4
-
Naltrexone Treatment of Alcohol Abuse in Schizophrenia
COMPLETED · Phase 4
-
Naltrexone, Craving, and Drinking
COMPLETED · Phase 4
-
Sertraline Pharmacotherapy for Alcoholism Subtypes
COMPLETED · Phase 4
-
Naltrexone for Heavy Drinking in Young Adults
COMPLETED · Phase 4
-
Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine)
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722561 · 302 participants · Phase 2
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
- NCT06015737 · 302 participants · Phase 3
A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus
- NCT07176273 · 302 participants · NA
Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia